Time to reset economy

Get App

Time to reset economy

SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Abbott India

Abbott India

BSE: 500488|NSE: ABBOTINDIA|ISIN: INE358A01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 28, 15:23
12630.00
-33.9 (-0.27%)
VOLUME 141
LIVE
NSE
Jan 28, 15:22
12655.75
-10.55 (-0.08%)
VOLUME 6,549
News on Abbott India
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Abbott India, target Rs 8,450: Dharmesh Shah

12.11 pm | 27 Dec 2018 |  Source: Moneycontrol.com

We expect the stock to resume fresh up move and test levels of Rs 8450 levels in the medium term, says Dharmesh Shah of ICICI Securities....

Buy ABB, target Rs 1550: Dharmesh Shah

12.09 pm | 07 Dec 2018 |  Source: Moneycontrol.com

We believe that the stock is likely to continue with its positive momentum and head towards Rs 1550 in the medium-term, says Dharmesh Shah of ICICIdir...

Buy ABB India, target Rs 1550: Dharmesh Shah

11.09 am | 30 Nov 2018 |  Source: Moneycontrol.com

The weekly 14-periods RSI has been inching upward after recently recording bullish crossover, indicating an acceleration of positive momentum in the s...

Abbott India Standalone September 2018 Net Sales at Rs 979.72 crore, up 5.24% Q-o-Q

10.02 am | 14 Nov 2018 |  Source: Moneycontrol.com

NULL...

Abbott India Q2 net profit up marginally at Rs 137.68 cr

10.38 pm | 13 Nov 2018 |  Source: PTI

Revenue from operations stood at Rs 979.72 crore for the quarter under consideration against Rs 930.98 crore for the same period a year ago....

Hold Abbott India; target of Rs 7250: Centrum

5.18 pm | 11 Oct 2018 |  Source: Moneycontrol.com

Centrum recommended hold rating on Abbott India with a target price of Rs 7250 in its research report dated October 10, 2018....

India may face medicine shortage after China cracks down on factories to check pollution

7.05 pm | 04 Oct 2018 |  Source: Moneycontrol.com

Media reports estimate 40 percent of all China factories have been shut down at some point in the last one year in order to be inspected by environmen...

Accumulate ABB, target Rs 1,540: Nandish Shah

11.47 am | 03 Oct 2018 |  Source: Moneycontrol.com

We recommend investors to accumulate ABB in the range of Rs 1,390-1,423 for the upside target of Rs 1,540, and a stop loss placed below Rs 1,360, says...

Buy or sell: Top stock trading ideas by market experts which are good short term bets

8.08 am | 03 Oct 2018 |  Source: Moneycontrol.com

Rajesh Agarwal of AUM Capital recommends buying Can Fin Homes with stop loss at Rs 252 and target of Rs 274 and Lakshmi Vilas Bank with stop loss at ...

Pharma weekly wrap: FDC ban and Shivinder Singh's U-turn hog the limelight

11.37 am | 16 Sep 2018 |  Source: Moneycontrol.com

The government ban on FDCs mostly covered drug cocktails for treating cold and cough, antibiotics, painkillers, anti-depressants, diabetic drugs, amon...

Abbott gets reprieve from Supreme Court in FDC ban case

6.48 pm | 10 Sep 2018 |  Source: Moneycontrol.com

The court directed the Central government to exclude 15 fixed dose combination (FDC) medications from the ban recommended by a sub-committee appointed...

Buy ABB India; target of Rs 1500: JM Financial

3.41 pm | 03 Sep 2018 |  Source: Moneycontrol.com

JM Financial is bullish on ABB India has recommended buy rating on the stock with a target price of Rs 1500 in its research report dated August 31, 20...

Abbott India lines up 100 product launches over the next 5 years

12.07 pm | 26 Aug 2018 |  Source: PTI

The Mumbai-based firm, which is a subsidiary of US-based Abbott Laboratories, had launched 21 new products in the country last fiscal....

Buy Abbott India; target of Rs 7530: Centrum

3.58 pm | 23 May 2018 |  Source: Moneycontrol.com

Centrum is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 7530 in its research report dated May 15, 2018....

Abbott discontinues selling Xience Alpine stents in India

3.05 pm | 26 Apr 2018 |  Source: PTI

The National Pharmaceutical Pricing Authority (NPPA) in a meeting on April 23 had approved the change in date of withdrawal of Xience Alpine brand of ...

Corona Remedies acquires two brands from Abbott

5.30 pm | 02 Apr 2018 |  Source: PTI

Both these brands are popular prescription drugs to manage diabetes and hyperthyroidism, Tejas Kothari, Head-Strategy at Corona said....

1
Quick Links for Abbott India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.